How to appeal a Highmark neurosurgery — discectomy, laminectomy, craniotomy, shunt denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

Highmark-specific note: Operates BCBS in PA (western), WV, DE, NY (western). Owns Allegheny Health Network.

What Highmark's policy requires for neurosurgery — discectomy, laminectomy, craniotomy, shunt

Cited policy: Anthem BCBS medical policy Cervical Total Disc Replacement (CADR)

Single-level (some plans 2-level) symptomatic cervical disc disease at C3-T1; failed >=6 wk conservative care; FDA-approved device; not for myelopathy with severe spinal cord compression OR ankylosing spondylitis.

How Highmark denies neurosurgery — discectomy, laminectomy, craniotomy, shunt — and how to counter it

Where Highmark pushes back: 1) Multi-level CADR 'experimental'; 2) ACDF should be tried first; 3) Patient not skeletally mature.

Counter-arguments that hold up: Mobi-C 2-level FDA approval (Aug 2013). Davis JNS Spine 2015 7-yr 2-level superior NDI to ACDF. Prestige LP 7-yr Burkus. AANS/CNS supports CADR alternative to ACDF for selected radiculopathy/myelopathy. Skeletal maturity documented on imaging.

What Highmark typically denies for neurosurgery — discectomy, laminectomy, craniotomy, shunt

Across Highmark's commercial and Medicare books, denials cluster around a small number of patterns. For neurosurgery — discectomy, laminectomy, craniotomy, shunt, expect:

• Prior auth on biologics
• PA on advanced imaging
• OON balance bills

Treatments most often denied in this category

These are the neurosurgery — discectomy, laminectomy, craniotomy, shunt treatments most often flagged for prior auth, step therapy, or medical necessity review:

• Lumbar discectomy
• Cervical discectomy
• Lumbar laminectomy
• Cervical laminectomy
• Lumbar fusion
• ACDF

How to submit the appeal to Highmark

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Highmark cited in the denial.
3. File the appeal through Highmark's portal (members: https://www.highmark.com ; providers: https://www.highmark.com/provider). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In PA, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See Highmark's prior-authorization criteria by drug: Highmark PA criteria on ApprovalHelp.